JenXplor is a modular robotic platform at the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI). It automates laboratory workflows, accelerates the search for new active compounds and opens up new experimental possibilities. This makes it possible to pursue approaches that would be difficult or even impossible to implement using conventional methods. The research group Robotic-Assisted Discovery of Antiinfectives uses JenXplor to identify promising compounds for the development of new antibiotics and antifungals.

JenXplor –
A modular robotic platform at the Leibniz-HKI

JenXplor is a modular robotic platform at the Leibniz-HKI that enables the automated execution of biological and biochemical experiments, ranging from individual workflow steps to complex, multi-step assays. The platform supports a broad range of experimental procedures, including phenotypic screening, molecular biology methods in natural product research and compound management. By automating experimental workflows, JenXplor increases throughput and enables systematic studies that would be highly labor-intensive, prone to error or even impossible to perform manually.

JenXplor consists of three complementary modules:

Drug-resistant pathogens

Background

The rise of resistant pathogens poses a major global health threat.

The spread of drug-resistant bacteria and fungi is advancing faster than the development of new effective therapies. As a result, infections are becoming increasingly difficult to treat. New antibiotics, antifungal agents and innovative therapeutic approaches are therefore urgently needed.

Contact us!

We are open to collaborations aimed at developing innovative approaches to address the antimicrobial resistance (AMR) crisis. Our work is guided by hypothesis-driven, collaborative research and focuses on the joint development of new concepts and strategies, rather than routine antimicrobial activity testing.

Our team